|
Earnings
| ShowHide Related Items >><< - 07/20/22
- Capri Holdings sees forex headwinds of $300M in FY23
- 07/20/22
- Capri Holdings interested in 'fashion luxury' acquisitions
- 07/20/22
- Capri Holdings targets long-term operating margin about 20%
- 07/20/22
- Capri Holdings up 2% as revenue targets discussed during investor day
- 07/28/22 Barclays
- Capri Holdings price target raised to $66 from $63 at Barclays
- 07/21/22 Credit Suisse
- Capri Holdings price target lowered to $56 from $65 at Credit Suisse
- 07/21/22 Goldman Sachs
- Capri Holdings price target lowered to $59 from $69 at Goldman Sachs
- 07/15/22 UBS
- Capri Holdings price target lowered to $65 from $91 at UBS
- 07/20/22
- Capri Holdings backs FY23 EPS view $6.85, consensus $6.83
- 06/01/22
- Capri Holdings provides quarterly FY23 guidance
- 06/01/22
- Capri Holdings sees Q1 EPS $1.35, consensus $1.45
- 06/01/22
- Capri Holdings sees FY23 EPS $6.85, consensus $6.57
- 07/20/22
- What You Missed On Wall Street On Wednesday
- 07/20/22
- What You Missed On Wall Street This Morning
- 06/01/22
- What You Missed On Wall Street On Wednesday
- 06/01/22
- What You Missed On Wall Street This Morning
- 07/25/22
- Largest borrow rate increases among liquid names
- 06/30/22
- Capri Holdings call volume above normal and directionally bullish
- 06/16/22
- Capri Holdings call volume above normal and directionally bullish
- 06/13/22
- Capri Holdings call volume above normal and directionally bullish
|
|
Hot Stocks
|
Planet Fitness announced… ShowHide Related Items >><< - 05/25/22
- Blue Apron adds partnerships with Blue Cross Blue Shield, Planet Fitness
- 05/10/22
- Planet Fitness announces development agreement in New Zealand
- 07/07/22 Exane BNP Paribas
- Planet Fitness upgraded to Neutral from Underperform at Exane BNP Paribas
- 06/13/22 Jefferies
- Jefferies names five top picks in lifestyle and growth platforms
- 06/07/22 Cowen
- Planet Fitness positioned to succeed despite macro challenges, says Cowen
- 05/25/22 Cowen
- Planet Fitness operating model remains resilient among headwinds, says Cowen
- 06:40 Today
- Planet Fitness sees FY22 adjusted EPS up mid-80% range
- 06:37 Today
- Planet Fitness reports Q2 adjusted EPS 38c vs. 21c last year
- 05/10/22
- Planet Fitness sees 2022 revenue increasing in mid-50 percent range
- 05/10/22
- Planet Fitness reports Q1 adjusted EPS 32c, consensus 27c
- 07/07/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/11/22
- What You Missed On Wall Street On Wednesday
- 05/11/22
- What You Missed On Wall Street This Morning
- 05/11/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
|
Recommendations
|
Baird analyst Collen Kusy… ShowHide Related Items >><< MRSN Mersana Therapeutics - 08/08/22
- Mersana to get $100M upfront fee from GSK for co-commercialization of XMT-2056
- 08/08/22
- Mersana Therapeutics trading resumes
- 08/08/22
- Mersana Therapeutics trading halted, news pending
- 05/23/22
- Mersana Therapeutics director Hack buys 216K shares of stock
- 08/08/22
- Mersana to get $100M upfront fee from GSK for co-commercialization of XMT-2056
- 08/08/22
- GSK, IQVIA launch Vaccine Track platform
- 07/29/22
- ViiV Healthcare presents five-year data at AIDS 2022 on fostemsavir
- 07/28/22
- ViiV Healthcare announces data from unblinded phase of HPTN 084 study
MRSN Mersana Therapeutics - 05/10/22 Baird
- Mersana Therapeutics price target lowered to $18 from $23 at Baird
- 05/09/22 H.C. Wainwright
- Mersana price target lowered to $19 from $24 at H.C. Wainwright
- 11/10/21 Baird
- Mersana Therapeutics price target lowered to $23 from $30 at Baird
- 10/14/21 BTIG
- Mersana Therapeutics assumed with a Buy at BTIG
- 08/08/22 UBS
- GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS
- 08/05/22 Morgan Stanley
- GSK plc resumed with an Equal Weight at Morgan Stanley
- 07/21/22 Citi
- GSK plc resumed with a Neutral at Citi
- 07/20/22 UBS
- GSK plc price target lowered to 1,850 GBp from 1,876 GBp at UBS
MRSN Mersana Therapeutics - 08/08/22
- Mersana Therapeutics reports Q2 EPS (55c), consensus (52c)
- 05/09/22
- Mersana Therapeutics reports Q1 EPS (59c), consensus (32c)
- 02/28/22
- Mersana Therapeutics reports Q4 EPS (68c), consensus (67c)
- 07/27/22
- GSK plc reports Q2 adjusted EPS 34.7p vs. 28.2p last year
- 04/27/22
- GlaxoSmithKline reaffirms FY22 sales growth between 5%-7% at CER
- 04/27/22
- GlaxoSmithKline reports Q1 adjusted EPS 32.8p vs. 22.9p last year
- 04/13/22
- GlaxoSmithKline backs FY22 revenue view up 5%-7% at CER, consensus $47.34B
- 07/18/22
- GSK CEO says split will help deal with 'perennial underperformance,' FT reports
- 06/27/22
- GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says
- 06/27/22
- GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says
- 06/06/22
- GSK rectal cancer trial yields remission in all 18 patients, NY Times reports
MRSN Mersana Therapeutics - 08/08/22
- Fly Intel: After-Hours Movers
- 04/14/22
- What You Missed On Wall Street This Morning
- 02/09/22
- Wall Street in Fives - Must Read Lists for Wednesday
- 02/09/22
- Wall Street in Fives - Must Read Lists at Midday
- 08/05/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 07/18/22
- What You Missed On Wall Street This Morning
- 07/18/22
- Fly Intel: Pre-market Movers
- 06/24/22
- What You Missed On Wall Street On Friday
- 07/29/22
- GSK plc (ADR) call volume above normal and directionally bullish
- 07/22/22
- Two new option listings and one option delisting on July 22nd
- 07/20/22
- One new option listing and two option delistings on July 20th
- 07/08/22
- GlaxoSmithKline call volume above normal and directionally bullish
|
|
Earnings
|
Reports Q2 revenue $6.1M,… ShowHide Related Items >><< - 07/25/22
- CommAgility introduces 5G Network Listening Mode software
- 06/21/22
- Wireless Telecom's Noisecom introduces 60 GHz jitter noise generator
- 06/15/22
- Wireless Telecom to showcase specialized solutions at IMS 2022
- 05/26/22
- Wireless Telecom's Boonton introduces NGX1000 Programmable Noise Generator
- 03/17/22
- Wireless Telecom reports Q4 EPS 2c vs. (25c) a year ago
- 02/10/22
- Wireless Telecom sees Q4 revenue $13.1M, consensus $13.39M
|
|
Recommendations
|
BMO Capital analyst Gary… ShowHide Related Items >><< - 06/17/22
- Scholar Rock announces new data from TOPAZ trial extension period
- 05/16/22
- Scholar Rock announces 25% workforce reduction
- 05/16/22
- Scholar Rock Chief Medical Officer to step down
- 07/12/22 Truist
- Scholar Rock initiated with a Buy at Truist
- 06/23/22 Piper Sandler
- Scholar Rock price target lowered to $19 from $28 at Piper Sandler
- 05/24/22 JPMorgan
- Scholar Rock price target lowered to $37 from $46 at JPMorgan
- 05/17/22 BMO Capital
- Scholar Rock price target lowered to $55 from $74 at BMO Capital
- 08/08/22
- Scholar Rock reports Q2 EPS ($1.06), consensus ($1.03)
- 05/16/22
- Scholar Rock reports Q1 EPS (21c), consensus (62c)
- 03/07/22
- Scholar Rock reports FY21 EPS ($3.59), consensus ($3.67)
|
|
Hot Stocks
|
Hormel Foods announced a… ShowHide Related Items >><< - 03/15/22 Goldman Sachs
- Hormel Foods downgraded to Sell from Neutral at Goldman Sachs
- 03/10/22 Argus
- Hormel Foods upgraded to Buy at Argus on pricing power
- 03/10/22 Argus
- Hormel Foods upgraded to Buy from Hold at Argus
- 01/25/22 Piper Sandler
- Hormel Foods price target lowered to $48 from $49 at Piper Sandler
- 06/02/22
- Hormel Foods cuts FY22 EPS view to $1.87-$1.97 from $1.87-$2.03
- 06/02/22
- Hormel Foods reports Q2 EPS 48c, consensus 47c
- 06/01/22
- Notable companies reporting before tomorrow's open
- 06/01/22
- Notable companies reporting before tomorrow's open
- 06/02/22
- What You Missed On Wall Street On Thursday
- 06/02/22
- What You Missed On Wall Street This Morning
- 03/15/22
- What You Missed On Wall Street On Tuesday
- 03/15/22
- What You Missed On Wall Street This Morning
- 03/01/22
- Early notable gainers among liquid option names on March 1st
|
|
Downgrade
|
Exane BNP Paribas analyst… ShowHide Related Items >><< - 07/27/22
- CarGurus appoints Javier Zamora as general counsel
- 07/19/22
- Skechers down 4% as short-seller Spruce Point sees 30%-50% downside risk
- 06/27/22
- Nike says taking 'cautious approach' to greater China in FY23
- 06/27/22
- Nike says digital now represents 24% of brand revenue
- 05:30 Today Exane BNP Paribas
- Nike downgraded to Neutral from Outperform at Exane BNP Paribas
- 07/25/22 Piper Sandler
- Nike assumed with a Neutral at Piper Sandler
- 07/21/22 KeyBanc
- KeyBanc transitions coverage of Global Brands & E-Commerce with cautious view
- 07/20/22 KeyBanc
- Nike initiated with a Sector Weight at KeyBanc
- 06/27/22
- Nike sees Q1 revenue growth flat to slightly up sequentially, consensus $12.88B
- 06/27/22
- Nike sees FY23 revenue growth in low double digits, consensus $51.57B
- 06/27/22
- Nike reports Q4 EPS 90c, consensus 81c
- 06/27/22
- Notable companies reporting after market close
- 06/23/22
- Cisco, Nike planning to fully exit Russia, Reuters reports
- 05/24/22
- Nike not renewing franchise deal with IRG, will leave Russia, Vedomosti says
- 05/18/22
- Nike's head of diversity to leave at end of July, FT reports
- 03/19/22
- Nike reports earnings Monday, investors shouldn't get hopes up, Barron's says
- 07/11/22
- Game On: Wedbush's Pachter calls GameStop chairman 'deluded'
- 06/28/22
- What You Missed On Wall Street On Tuesday
- 06/28/22
- What You Missed On Wall Street This Morning
- 06/28/22
- Fly Intel: Pre-market Movers
- 07/05/22
- Early notable gainers among liquid option names on July 5th
- 06/29/22
- Early notable gainers among liquid option names on June 29th
- 06/27/22
- Nike options imply 8.0% move in share price post-earnings
- 06/27/22
- Unusually active option classes on open June 27th
|
|
Earnings
| ShowHide Related Items >><< - 07/27/22
- Vivid Seats, Rolling Stone announce a multi-faceted partnership
- 06/30/22
- Vivid Seats announces expiration, results of exchange offer
- 06/16/22
- Vivid Seats to join Russell 2000, Russell 3000 Indexes
- 05/26/22
- Vivid Seats board authorizes $40M share repurchase program
- 07/14/22 Piper Sandler
- Vivid Seats initiated with a Neutral at Piper Sandler
- 07/07/22 Citi
- Vivid Seats price target lowered to $12 from $14 at Citi
- 05/10/22 Raymond James
- Vivid Seats price target lowered to $11 from $17 at Raymond James
- 03/11/22 Benchmark
- Vivid Seats price target lowered to $17 from $19 at Benchmark
- 06:42 Today
- Vivid Seats reports Q2 rvenue $147.7M, consensus $125.4M
- 05/10/22
- Vivid Seats raises FY22 revenue view to $520.0M-$555.0M from $510.0M-$550.0M
- 05/10/22
- Vivid Seats reports Q1 revenue $130.8M, consensus $113.83M
- 03/10/22
- Vivid Seats sees 2022 revenue $510M-$550M, consensus $554.44M
|
|
Recommendations
| ShowHide Related Items >><< - 07/25/22
- Castle Biosciences announces DecisionDx-Melanoma surpasses 100,000 tests ordered
- 06/22/22
- Castle Biosciences announces data showing value of skin cancer tests
- 05/24/22
- Castle Biosciences announces results from TissueCypher Barrett's Esophagus study
- 05/19/22
- Castle Biosciences' DecisionDx-SCC shows risk-stratification efficacy in study
- 05/19/22 Baird
- Baird says final LCD for test 'incrementally positive' for Castle Biosciences
- 05/10/22 Canaccord
- Castle Biosciences price target lowered to $65 from $80 at Canaccord
- 05/10/22 Baird
- Castle Biosciences price target lowered to $44 from $50 at Baird
- 05/09/22 BTIG
- Castle Biosciences transferred with a Buy at BTIG
- 08/08/22
- Castle Biosciences raises FY22 revenue view to $130M-$135M from $118M-$123M
- 08/08/22
- Castle Biosciences reports Q2 EPS (6c), consensus (76c)
- 05/09/22
- Castle Biosciences raises FY22 revenue view to $118M-$123M from $115M-$120M
- 05/09/22
- Castle Biosciences reports Q1 EPS (97c), consensus (71c)
- 04/04/22
- Fly Intel: After-Hours Movers
|
|
Hot Stocks
| ShowHide Related Items >><< - 07/29/22
- Nielsen receives regulatory approval for proposed transaction
- 07/25/22
- ISS recommends Nielsen holders vote 'FOR' proposed transaction
- 06/16/22
- Magnite expands measurement, attribution program for currency optionality
- 05/16/22
- Elliott adds Diamond Offshore, exits Arconic in Q1
- 05/16/22 BMO Capital
- Nielsen downgraded to Market Perform from Outperform at BMO Capital
- 03/30/22 Jefferies
- Nielsen downgraded to Hold from Buy at Jefferies
- 03/29/22 Morgan Stanley
- Morgan Stanley raises Nielsen to Equal Weight, says 'may be better off private'
- 03/29/22 Morgan Stanley
- Nielsen upgraded to Equal Weight from Underweight at Morgan Stanley
- 07/27/22
- Nielsen backs FY22 adjusted EPS $1.81-$1.91, consensus $1.88
- 07/27/22
- Nielsen reports Q2 adjusted EPS 46c, consensus 43c
- 04/28/22
- Nielsen backs FY22 adjusted EPS $1.81-$1.91, consensus $1.83
- 04/28/22
- Nielsen reports Q1 adjusted EPS 45c, consensus 40c
- 04/22/22
- U.K. probing WindAcre stake in Nielsen, Bloomberg reports
- 04/07/22
- WindAcre offer to support Nielsen buyout quickly rejected, Bloomberg says
- 03/22/22
- Elliott, Brookfield mull raising offer for Nielsen, Bloomberg reports
- 03/22/22
- Elliott, Brookfield mull raising offer for Nielsen, Bloomberg reports
- 05/16/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/30/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/29/22
- What You Missed On Wall Street On Tuesday
- 03/29/22
- What You Missed On Wall Street This Morning
- 03/29/22
- Early notable gainers among liquid option names on March 29th
- 03/22/22
- Nielsen call volume above normal and directionally bullish
|
